A method for high-throughput gene expression signature analysis
Peck, D., E. D. Crawford, K. N. Ross, K. Stegmaier, T. R. Golub, and J. Lamb. 2006. “A Method for High-Throughput Gene Expression Signature Analysis”. Genome Biol 7: R61.
Search
Search results
305 results found
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
Pikman, Y., B. H. Lee, T. Mercher, E. McDowell, B. L. Ebert, M. Gozo, A. Cuker, et al. 2006. “MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis With Myeloid Metaplasia”. PLoS Med 3: e270.
Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Raj, L., T. Ide, A. U. Gurkar, M. Foley, M. Schenone, X. Li, N. J. Tolliday, et al. 2018. “Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS”. Nature 561: 420.
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., P. Tamayo, R. Rifkin, S. Mukherjee, C. H. Yeang, M. Angelo, C. Ladd, et al. 2001. “Multiclass Cancer Diagnosis Using Tumor Gene Expression Signatures”. Proc Natl Acad Sci U S A 98: 15149-54.
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Slabicki, M., Z. Kozicka, G. Petzold, Y. D. Li, M. Manojkumar, R. D. Bunker, K. A. Donovan, et al. 2020. “The CDK Inhibitor CR8 Acts As a Molecular Glue Degrader That Depletes Cyclin K”. Nature 585: 293-97.